Bioptimus builds AI foundation models for biology, transforming multiscale biological data into actionable insights for the biomedicine sector. The company operates at the intersection of AI for biology, foundation models, digital pathology, and computer vision, with applications spanning drug discovery, clinical trials, and research and development.
The company's flagship product, H-Optimus, is an AI foundation model for digital pathology that ranks first out of 22 comparable foundation models. Bioptimus has trained its models on 2 billion images, drawing on data from over 4,000 clinical practices. Its foundation models are approaching 1 million downloads and are cited in approximately 100 scientific publications annually.
Bioptimus has secured $76 million in funding to support its work in building large-scale AI systems for biological data analysis.
